Patients N %
Patients with evaluable compliance data 1,015 100.0
SQ grass SLIT-tablet daily administered    
Regularly 732 72.1
Irregularly 283 27.9
Patients lost-to-follow-up 158 14.2
Premature termination due to lack of compliance 14 1.3
Missing control visits 160 14.4
Patients with frequent irregular administration 40 3.6
Assessment of easiness and convenience of taking the SQ grass SLIT-tablet 807 100.0
‘Easy and convenient’ 723 89.6
‘So-so’ 81 10.0
‘Difficult and inconvenient’ 3 0.4
Assessment of satisfaction with efficacy of treatment 796 100.0
Very satisfied 368 46.2
Satisfied 369 46.4
Dissatisfied 56 7.0
Very dissatisfied 3 0.4
N: Number of patients
SLIT: Sublingual immunotherapy
Table 3: Compliance and patient satisfaction.
Goto home»